{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:20:39Z","timestamp":1792840839887,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jpba.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T06:34:51Z","timestamp":1549780491000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat"],"prefix":"10.1016","volume":"168","author":[{"given":"Ziwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-1878","authenticated-orcid":false,"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-6157","authenticated-orcid":false,"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.02.004_bib0005","first-page":"1191","article-title":"In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450S","volume":"25","author":"Prueksaritanont","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2019.02.004_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2133\/dmpk.DMPK-12-RV-042","article-title":"The emerging role of human esterases","volume":"27","author":"Fukami","year":"2012","journal-title":"Drug Metab. Pharmacok."},{"key":"10.1016\/j.jpba.2019.02.004_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors - similarities and differences","volume":"32","author":"Lennernas","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2019.02.004_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1248\/bpb.b14-00679","article-title":"Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin","volume":"38","author":"Wang","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2019.02.004_bib0025","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M004543200","article-title":"Rabbit serum paraoxonase 3 (PON3) is a high-density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation","volume":"275","author":"Draganov","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2019.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2019.02.004_bib0035","first-page":"1335","article-title":"Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billeclke","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2019.02.004_bib0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00210-003-0833-1","article-title":"Pharmacogenetics of paraoxonases: a brief review","volume":"369","author":"Draganov","year":"2004","journal-title":"N-S Arch. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.38.1.257","article-title":"The mammalian carboxylesterases: from molecules to functions","volume":"38","author":"Satoh","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jpba.2019.02.004_bib0055","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/pmic.200900105","article-title":"Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma","volume":"9","author":"Na","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jpba.2019.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.bcp.2005.01.017","article-title":"Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: Its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma","volume":"69","author":"Furihata","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0892-0362(90)90071-J","article-title":"Distribution and some biochemical properties of rat paraoxonase activity","volume":"12","author":"Pellin","year":"1990","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-2952(93)90373-5","article-title":"Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood","volume":"45","author":"McCracken","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00041433-200406000-00005","article-title":"Paraoxonase, a cardioprotective enzyme: continuing issues","volume":"15","author":"Getz","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-2797(01)00225-3","article-title":"Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role","volume":"137","author":"Rodrigo","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpba.2019.02.004_bib0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj20030732","article-title":"Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties","volume":"376","author":"Rodrigo","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.jpba.2019.02.004_bib0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3210595","article-title":"Purification and characterization of paraoxon hydrolase from rat liver","volume":"321","author":"Rodrigo","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.jpba.2019.02.004_bib0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-1119(98)00193-0","article-title":"Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence","volume":"213","author":"Mochizuki","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.jpba.2019.02.004_bib0100","doi-asserted-by":"crossref","first-page":"G1252","DOI":"10.1152\/ajpgi.00369.2007","article-title":"Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats","volume":"293","author":"Levy","year":"2007","journal-title":"Am. J. Physiol. Gastr. L."},{"key":"10.1016\/j.jpba.2019.02.004_bib0105","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0110","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2019.02.004_bib0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1345\/aph.1G462","article-title":"Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity","volume":"40","author":"Ricaurte","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jpba.2019.02.004_bib0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/medicina48070056","article-title":"Paracetamol and simvastatin: a potential interaction resulting in hepatotoxicity","volume":"48","author":"Gumbrevicius","year":"2012","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.jpba.2019.02.004_bib0125","first-page":"172","article-title":"Potential drug interaction between simvastatin and danazol causing rhabdomyolysis","volume":"10","author":"Andreou","year":"2003","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ajhp\/59.8.728","article-title":"Rhabdomyolysis due to probable interaction between simvastatin and ritonavir","volume":"59","author":"Cheng","year":"2002","journal-title":"Am. J. Health. Syst. Pharm."},{"key":"10.1016\/j.jpba.2019.02.004_bib0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/clpt.2012.57","article-title":"The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy","volume":"92","author":"Wilke","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2019.02.004_bib0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0731-7085(99)00231-9","article-title":"Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form","volume":"21","author":"Wang","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.02.004_bib0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-4347(97)00091-1","article-title":"Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene","volume":"694","author":"Ochiai","year":"1997","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2019.02.004_bib0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/bms.1200190910","article-title":"A selected ion monitoring method for quantifying simvastatin and its acid form in human plasma, using the ferroceneboronate derivative","volume":"19","author":"Takano","year":"1990","journal-title":"Biomed. Environ. Mass Spectrom."},{"key":"10.1016\/j.jpba.2019.02.004_bib0155","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jaoac\/88.6.1631","article-title":"Stability study of simvastatin under hydrolytic conditions assessed by liquid chromatography","volume":"88","author":"Alvarez-Lueje","year":"2005","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jpba.2019.02.004_bib0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10311-009-0207-0","article-title":"Stability studies of cholesterol lowering statin drugs in aqueous samples using HPLC and LC-MS","volume":"8","author":"Piecha","year":"2009","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.jpba.2019.02.004_bib0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2013.12.030","article-title":"Simultaneous quantification of simvastatin and simvastatin hydroxy acid in blood serum at physiological pH by ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC\/MS\/MS)","volume":"947","author":"Bews","year":"2014","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2019.02.004_bib0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpba.2005.11.020","article-title":"Validated HPLC-MS\/MS method for simultaneous determination of simvastatin and simvastatin hydroxy acid in human plasma","volume":"41","author":"Barrett","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.02.004_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4062\/biomolther.2011.19.2.248","article-title":"Evaluation of pharmacokinetics of simvastatin and its pharmacologically active metabolite from controlled-release tablets of simvastatin in rodent and canine animal models","volume":"19","author":"Shanmugam","year":"2011","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.jpba.2019.02.004_bib0180","series-title":"Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"key":"10.1016\/j.jpba.2019.02.004_bib0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation","volume":"344","author":"Zhu","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2019.02.004_bib0190","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1124\/jpet.106.110577","article-title":"Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol","volume":"319","author":"Tang","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2019.02.004_bib0195","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.2536901100","article-title":"Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization","volume":"101","author":"Aharoni","year":"2004","journal-title":"P. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jpba.2019.02.004_bib0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0006-2952(69)90050-1","article-title":"Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in rat by carboxylesterase inhibitor bis-[p-nitrophenyl] phosphate","volume":"18","author":"Heymann","year":"1969","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2019.02.004_bib0205","first-page":"138","article-title":"Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug","volume":"18","author":"Vickers","year":"1990","journal-title":"Drug Metab. Dispo."},{"key":"10.1016\/j.jpba.2019.02.004_bib0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpba.2006.02.015","article-title":"RP-HPLC determination of paraoxonase 3 activity in human blood serum","volume":"42","author":"Suchocka","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.02.004_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","article-title":"The three-gene paraoxonase family: physiologic roles, actions and regulation","volume":"214","author":"Pr\u00e9court","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpba.2019.02.004_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188633","article-title":"Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients","volume":"12","author":"Arenas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2019.02.004_bib0225","first-page":"1022","article-title":"Interindividual variation in carboxylesterase levels in human liver microsomes","volume":"23","author":"Hosokawa","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2019.02.004_bib0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/hdy.2008.110","article-title":"Determinants of variation in human serum paraoxonase activity","volume":"102","author":"Rainwater","year":"2009","journal-title":"Heredity"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851832274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851832274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T06:19:10Z","timestamp":1606457950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851832274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":46,"alternative-id":["S073170851832274X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.02.004","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}